Related Experiment Video
Updated: Apr 27, 2026

Modeling Fast-scan Cyclic Voltammetry Data from Electrically Stimulated Dopamine Neurotransmission Data Using QNsim1.0
Published on: June 5, 2017
Quantification of neocortical slice diffusion characteristics using pharmacokinetic and pharmacodynamic modelling
Logan J Voss1, Claudia van Kan2, James W Sleigh3
1Anaesthesia Department, Waikato District Health Board, Pembroke St, Hamilton 3240, New Zealand.
Pharmacokinetic/pharmacodynamic (PKPD) modeling can estimate drug diffusion times in brain slices. This method accurately determined anesthetic and ion diffusion rates, aiding future research.
Area of Science:
- Neuroscience
- Pharmacology
- Computational Biology
Background:
- Drug delivery in brain slice experiments relies on passive diffusion due to the absence of blood supply.
- Ensuring adequate drug penetration into deeper tissue layers is a significant challenge.
Purpose of the Study:
- To investigate the applicability of pharmacokinetic/pharmacodynamic (PKPD) modeling for estimating drug diffusion times in neocortical brain slices.
- To assess the diffusion characteristics of anesthetic agents and ions in brain tissue.
Main Methods:
- Seizure-like event (SLE) activity was induced in 400 μm thick neocortical brain slices.
- Etomidate, thiopental, and magnesium ions were applied to reduce SLE frequency.
- Concentration-effect hysteresis loops were analyzed using a first-order rate constant model to derive equilibrium half-lives (t1/2Ke0).
Main Results:
- PKPD modeling successfully estimated diffusion and equilibration rates.
- Median t1/2Ke0 for etomidate was 83.1 min, consistent with slow diffusion.
- Magnesium ions exhibited a faster equilibration rate (t1/2Ke0 = 26.1 min) than anesthetics (etomidate and thiopental, t1/2Ke0 = 111.8 min).
Conclusions:
- PKPD modeling offers a practical approach to quantify drug diffusion in brain slice preparations.
- This method can provide valuable insights into drug penetration and equilibration dynamics in ex vivo brain tissue.
- Findings support the use of PKPD modeling for optimizing experimental designs in neuropharmacology.
More Related Videos
06:18Brain Slice Biotinylation: An Ex Vivo Approach to Measure Region-specific Plasma Membrane Protein Trafficking in Adult Neurons
Published on: April 3, 2014
10:45Real-time Iontophoresis with Tetramethylammonium to Quantify Volume Fraction and Tortuosity of Brain Extracellular Space
Published on: July 24, 2017
Related Concept Videos
Physiological Pharmacokinetic Models: Blood Flow-Limited Versus Diffusion-Limited Models
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Pharmacokinetic Models: Overview
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
Pharmacokinetic–Pharmacodynamic Relationship: Model Components
Pharmacodynamic Models: Overview